🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 16 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/04/2025 45,20 48,32 44,97 46,95 +4,26% 7,41% 2.147.600
14/04/2025 43,22 45,51 42,53 45,03 +5,65% 6,91% 1.162.800
11/04/2025 41,10 42,63 41,10 42,62 +4,23% 3,72% 1.157.700
10/04/2025 41,44 43,00 39,90 40,89 -3,95% 7,49% 1.638.900
09/04/2025 41,06 43,91 39,60 42,57 +2,16% 10,50% 1.868.900
08/04/2025 44,10 45,88 40,88 41,67 -3,56% 11,34% 2.073.400
07/04/2025 43,42 45,32 42,44 43,21 -2,77% 6,63% 1.590.200
04/04/2025 45,09 46,45 43,93 44,44 -4,43% 5,59% 1.749.600
03/04/2025 47,06 47,25 45,79 46,50 -3,53% 3,10% 1.482.000
02/04/2025 46,68 48,93 46,39 48,20 +2,82% 5,45% 1.223.100
01/04/2025 47,99 48,68 46,54 46,88 -3,06% 4,46% 1.095.300
31/03/2025 47,92 48,80 47,09 48,36 -1,06% 3,57% 1.211.800
28/03/2025 49,47 50,48 48,80 48,88 -1,13% 3,41% 664.500
27/03/2025 49,33 50,52 49,33 49,44 -0,24% 2,42% 715.400
26/03/2025 51,09 51,40 49,40 49,56 -2,92% 3,92% 881.900
25/03/2025 52,60 53,58 50,72 51,05 -2,82% 5,44% 790.400
24/03/2025 53,30 53,70 51,61 52,53 -0,23% 3,92% 1.521.900
21/03/2025 53,23 53,23 51,06 52,65 -0,75% 4,08% 3.695.700
20/03/2025 53,67 54,11 52,47 53,05 -2,39% 3,06% 890.900
19/03/2025 54,45 54,54 52,43 54,35 -0,31% 3,88% 1.048.600
18/03/2025 52,58 54,55 51,84 54,52 +2,85% 5,15% 784.600
17/03/2025 54,16 54,25 52,26 53,01 -3,23% 3,67% 1.284.600
14/03/2025 55,00 55,39 53,53 54,78 -0,22% 3,38% 1.271.500
13/03/2025 57,90 58,70 54,79 54,90 -4,77% 6,75% 1.399.200
12/03/2025 59,58 60,60 56,66 57,65 -3,53% 6,61% 2.252.400
11/03/2025 55,90 60,14 54,12 59,76 +6,81% 10,77% 2.617.900
10/03/2025 50,08 57,97 48,50 55,95 +45,89% 18,92% 5.227.800
07/03/2025 38,89 39,90 37,94 38,35 -1,79% 5,04% 1.598.900
06/03/2025 37,92 39,40 37,92 39,05 +1,56% 3,90% 1.033.300
05/03/2025 38,78 39,64 37,67 38,45 -0,54% 5,08% 1.509.600